Vanda Pharmaceuticals, Inc. (VNDA)
6.63
+0.40
(+6.42%)
USD |
NASDAQ |
Dec 15, 16:00
6.76
+0.13
(+1.96%)
After-Hours: 20:00
Vanda Pharmaceuticals Research and Development Expense (Annual): 74.43M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| ADMA Biologics, Inc. | 1.813M |
| Aldeyra Therapeutics, Inc. | 48.22M |
| Exelixis, Inc. | 910.41M |
| Anavex Life Sciences Corp. | 37.59M |